Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
This study is currently recruiting participants.
Verified August 2010 by McGill University
Study NCT00794573   Information provided by McGill University

First Received on November 19, 2008.   Last Updated on December 14, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Coronary Syndrome
Additional conditions recognized in this trial
Smoking
More general conditions related to this trial
Angina Pectoris
Cardiovascular Diseases
Chest Pain
Habits
Heart Diseases
Myocardial Ischemia
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
varenicline
placebo
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
McGill University
St. Michael's Hospital, Toronto
Sunnybrook Health Sciences Centre


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services